peter zhou

Groundbreaking UK Study Shows Key Enzyme Missing from Aggressive Form of Breast Cancer

A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain — providing insight into potential therapeutic targets to treat the aggressive cancer.
Subscribe to RSS - peter zhou
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading